DEVICE CATEGORY · QQT
Immunohistochemistry Assay, Antibody, Ki-67
The Ki-67 antibody is a qualitative immunohistochemical antibody intended to identify Ki-67 protein expression in human clinical tissue specimens. The KI-67 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Ki-67 IHC MIB-1 pharmDx (Dako Omnis)P210026/S003 | Agilent Technologies, Inc. | PMA supplement | Sep 11, 2026 | FDA |
Ki-67 IHC pharmDxP210026 | Agilent Technologies, Inc. | PMA approval | Oct 12, 2021 | FDA |
Source information
Follow the FDA links to view the original records.

